Completed Clinical Trials

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

By April 24, 2017 No Comments

Condition

Non-small Cell Lung Cancer|Mesothelioma|Lung Neoplasms

Estimated Enrollment: 31

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 10426|H3E-MC-JMHX

Study First Received: April 18, 2006

Last Updated: June 10, 2010

Estimated Primary Completion Date: March 2009

 

Primary Outcome Measures:

Overview of Adverse Events|Number of Participants With Common Toxicity Criteria – National Cancer Institute Grade 3 and Grade 4 Toxicities|Pemetrexed Population Pharmacokinetics (PK): Clearance|Pemetrexed Population Pharmacokinetics: Volume of Distribution|Discontinuations Due to Adverse Events

Sponsors and Collaborators:

Eli Lilly and Company

Website Link: https://ClinicalTrials.gov/show/NCT00316225

Leave a Reply

Call Now